Webinar
PRO Scheduling Considerations: Assessing Patient & Caregiver Burden in Clinical Trials
![A Conversation with Dr. Elin Haf Davies of Aparito](/sites/default/files/styles/1000px_wide_webp/public/2023-05/cons_and_ops.png.png.webp?itok=PQE9CIX-)
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Andrew Lloyd, Director at Acaster-Lloyd Consulting, to spotlight the burden of clinical research for patients, and their caregiver/family dynamics. From ethical considerations surrounding patient/caregiver consent, to the intricate timing challenges of data collection, the conversation examines how involvement in a study impacts on disease states and patient wellbeing, with further insight into how burden is extended to families and caregivers.
![Andrew Lloyd](/sites/default/files/styles/240x240_media_thumbnail/public/2024-02/acaster-lloyd-andrew.jpeg?itok=dmBrIxhX)
Andrew Lloyd
Director, Acaster-Lloyd
![Mark Wade](/sites/default/files/styles/240x240_media_thumbnail/public/2023-06/mark.png?itok=Q1T5q-2U)
Mark Wade
Global Practice Leader, TransPerfect Life Sciences
![Webinar cover image](themes/custom/tpls/assets/img/webinar-cover.png)